Coca-Cola Appeals National Advertising Division Recommendation to Discontinue or Modify Powerade “50% More Electrolytes” Claims

New York, NY – August 10, 2023 – The National Advertising Division (NAD) of BBB National Programs recommended that The Coca-Cola Company modify or discontinue claims for its Powerade sports drink stating:

  • “50% more electrolytes* vs the leading sports drink” 
  • “50% more electrolytes vs. Gatorade Thirst Quencher”

 

The claims at issue, which appear on Powerade packaging, two video commercials, and on Powerade social media pages were challenged by Stokely-Van Camp, manufacturer of Gatorade. Until recently, both Powerade and Gatorade Thirst Quencher had the same electrolyte content. Earlier this year, Coca-Cola introduced a reformulated product with an increased electrolyte load. 

Although Powerade contains 50% more potassium and sodium by weight than Gatorade, NAD concluded that Coca-Cola’s “50% more electrolytes” claims overstated the significance of the nutrient difference and that standing alone and in the context of its commercials and social media reasonably conveyed the implied message that Powerade provides better performance and hydration than Gatorade. 

Further, NAD determined that Coca-Cola’s social media “Strong Arm” emoji post conveyed an additional message that Powerade helps make you stronger than Gatorade.

These messages were not supported by the evidence in the record, so NAD recommended that Coca-Cola discontinue its “50% more electrolytes” claims or modify them to avoid conveying the message that Powerade provides a material increase in electrolytes or better performance or hydration than Gatorade or that drinking Powerade will make you stronger than drinking Gatorade.

NAD also concluded that Coca-Cola’s “50% more electrolytes” claims did not convey a message that Powerade is healthier than Gatorade.

In its advertiser statement, Coca-Cola stated that it will appeal NAD’s decision in its entirety. Coca-Cola further stated, “while we respect the NAD process and appreciate its efforts to reach a suitable solution, we disagree with its reasoning and analysis, and believe consumers are entitled to accurate information about the ingredients in food and beverages they purchase.”

Appeals of NAD decisions are made to the BBB National Programs’ National Advertising Review Board (NARB), the appellate-level truth-in-advertising body of BBB National Programs. 

All BBB National Programs case decision summaries can be found in the case decision library. For the full text of NAD, NARB, and CARU decisions, subscribe to the online archive. Per NAD Procedures, this release shall not be used for advertising or promotional purposes.

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product

New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.

Read the Decision Summary
Decision

National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin

New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin. 

Read the Decision Summary
Decision

In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products

New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.” 

Read the Decision Summary
Decision

National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies

New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.

Read the Decision Summary